Abstract
Thirteen adult common marmosets (Callithrix jacchus) were given once-monthly injections of haloperidol decanoate (5-15 mg/kg i.m.) for one year. Thereafter, drug-free and treatment periods alternated at 3-month intervals. After 2.5 to 14 months, 12 monkeys showed symptoms of tardive dyskinesia (TD), such as periocular and perioral twitchings, tongue protrusions, masticatory movements, and choreic movements in arms and legs. When TD symptoms were evident, the periodic treatment was interrupted and symptoms persisted for at least 5 months after the last haloperidol dose, worsened by injection of the anticholinergic drug biperiden. An injection of nondepot haloperidol (0.12 or 0.25 mg/kg) produced a reduction of TD symptoms. At the end of the study, nondepot haloperidol was injected once a week at two doses (0.12 and 0.25 mg/kg i.m.). A syndrome of excitation with peculiar behavior, interpreted as acute dystonia, was precipitated in all animals. The animals showed sustained retrocollis, climbing upside down, biting the perch, repetitive turnings, and frequent backward movements. The dystonic movements lasted approximately 6 hours and were reduced but not completely extinguished by biperiden (0.1 mg/kg). The TD syndrome registered ...Continue Reading
References
Jun 21, 1979·Psychopharmacology·L M Gunne, S Bárány
Jun 1, 1977·Brain : a Journal of Neurology·B S MeldrumC D Marsden
Aug 1, 1977·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P BédardL Larochelle
Aug 16, 1977·Psychopharmacology·B WeissG Lusink
Nov 24, 1976·Psychopharmacology·L M Gunne, S Bárány
Jul 1, 1977·The American Journal of Psychiatry·C A TammingaJ M Davis
Jan 1, 1975·Psychopharmacologia·A C SayersH Asper
Jan 1, 1990·Neuroscience·P E JohanssonL Gunne
Sep 1, 1990·The American Journal of Psychiatry·R YassaG Schwartz
Jan 1, 1990·Psychopharmacology·C A TammingaN Kaneda
Oct 1, 1986·Pharmacology, Biochemistry, and Behavior·L M GunneP Johansson
Jan 1, 1986·Psychopharmacology·J D SalamoneS D Iversen
Aug 1, 1988·Journal of Clinical Psychopharmacology·J LiebermanJ Kane
Jan 1, 1973·The American Journal of Psychiatry·H L Klawans
Jun 17, 1967·Nature·E L Schelkunov
Jan 1, 1980·Neuropsychobiology·G B BurnettS H Synder
Jan 1, 1980·Psychopharmacology·J Liebman, R Neale
Jan 1, 1980·Psychopharmacology·R B Glassman, H N Glassman
Jan 1, 1981·Psychopharmacology·R D Porsolt, M Jalfre
Jan 1, 1982·Psychopharmacology·L M GunneB Glaeser
Jan 1, 1982·Psychopharmacology·D M Coward
May 16, 1983·Life Sciences·M N RupniakC D Marsden
Feb 1, 1984·Journal of Clinical Psychopharmacology·M Branchey, L Branchey
May 24, 1984·Nature·L M GunneB Sjöquist
Jan 1, 1980·Psychopharmacology·D E CaseyE Christensson
Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·P J BédardL Larochelle
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·T FukuokaM Matsuo
Jun 18, 1998·Psychopharmacology·T HashimotoC A Tamminga
Jun 19, 1998·Psychopharmacology·S C Fowler, G Wang
Citations
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph H Friedman
Mar 13, 2012·Behavioral and Brain Functions : BBF·Pierre J BlanchetDaniel Lévesque
Nov 22, 2008·Progress in Neurobiology·Dominique GuehlPierre Burbaud
Jul 22, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Peter Jenner
Mar 21, 2017·Frontiers in Neurology·Gaetana ChillemiAngelo Quartarone
Mar 18, 2005·Journal of Neuroscience Research·A IwanamiH Okano
Jul 29, 2017·Expert Review of Neurotherapeutics·Haitham SalemAntonio L Teixeira
Apr 16, 2004·The Veterinary Record·D Espinosa-AvilésP Varela